AMAG Pharma (AMAG) Completes $700M Cord Blood Registry Acquisition
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street dips as higher yields, rising oil prices mark shaky start to SeptemberÂ
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
AMAG Pharmaceuticals Completes Acquisition of Cord Blood Registry
August 17, 2015 4:00 PM EDTExpands company's growing maternal health business Transaction expected to be immediately accretive Company anticipates seamless integration and is well positioned for future acquisitions
WALTHAM, Mass., Aug. 17, 2015 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (AMAG) (Nasdaq: AMAG) announced today that it has completed the acquisition of Cord Blood Registry®(CBR®), the world's largest umbilical cord blood stem cell collection and storage company serving pregnant women and their families, for $700 million in cash (subject to certain adjustments). The transaction was announced on June 29, 2015, and is expected to be immediately accretive to... More
